Real-World Evaluation of the Impact of the Anti-fibrotics in Patients with Idiopathic Pulmonary Fibrosis and Other Fibrotic Lung Diseases

被引：0
|
作者：
Dempsey, T. M. [1 ]
Thao, V. [2 ]
Sangaralingham, L. [2 ]
Limper, A. H. [3 ]
机构：
[1] David Grant Med Ctr, Pulm & Crit Care, Travis AFB, CA USA
[2] Mayo Clin, Kern Ctr Study Hlth Care Delivery, Rochester, MN USA
[3] Mayo Clin, Div Pulm & Crit Care, Rochester, MN USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 205卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2429
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Real-World Maintenance Strategies and Persistence with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
    Lancaster, L. H.
    Burg, C. A.
    Haselkorn, T.
    Yang, M.
    Corral, M.
    Stauffer, J. L.
    Huggins, J. T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [32] Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
    Amati, Francesco
    Stainer, Anna
    Mantero, Marco
    Gramegna, Andrea
    Simonetta, Edoardo
    Suigo, Giulia
    Voza, Antonio
    Nambiar, Anoop M.
    Cariboni, Umberto
    Oldham, Justin
    Molyneaux, Philip L.
    Spagnolo, Paolo
    Blasi, Francesco
    Aliberti, Stefano
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (02)
  • [33] A HUMAN MODEL OF LUNG FIBROSIS FOR THE ASSESSMENT OF ANTI-FIBROTIC STRATEGIES IN IDIOPATHIC PULMONARY FIBROSIS
    Roach, K. M.
    Tongue, P.
    Castells, E.
    Elliot, G.
    Marshall, H.
    Richardson, M.
    Mason, S.
    Chachi, L.
    Bradding, P.
    THORAX, 2019, 74 : A56 - A57
  • [34] Real-World Medication Adherence Trajectories of Nintedanib Among Idiopathic Pulmonary Fibrosis Patients
    Epstein, A. J.
    Nili, M.
    Nunag, D.
    Olson, A.
    Borah, B. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [35] Antifibrotic Dosing Patterns in Patients With Idiopathic Pulmonary Fibrosis in Real-World Data Sources
    Swaminathan, A. C.
    Stevens, S. R.
    Guidot, D. M.
    Elpers, B.
    Chopra, P.
    Palmer, S. M.
    Wruck, L. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [36] Real-world antifibrotic treatment persistence and clinical outcomes for patients with idiopathic pulmonary fibrosis
    Qiu, Ying
    Zhu, Julia
    Elpers, Brandon
    Jiang, Jenny
    Ogbomo, Adesuwa
    Mallampati, Rajesh
    Byrne, Clare
    Tang, Jackson
    Fischer, Aryeh
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [37] Characteristics of a Real-World Canadian Cohort of Patients with Idiopathic Pulmonary Fibrosis Treated with Pirfenidone
    Ryerson, C.
    Kolb, M. R. J.
    Cox, G. P.
    Shapera, S.
    Swigris, J. J.
    Fell, C. D.
    O'Brien, M.
    Yang, M.
    Cabalteja, C.
    Mendoza, O. Moran
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [38] A Narrative Review of Real-World Data on the Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis
    Podolanczuk, Anna J.
    Cottin, Vincent
    ADVANCES IN THERAPY, 2023, 40 (05) : 2038 - 2050
  • [39] A Narrative Review of Real-World Data on the Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis
    Anna J. Podolanczuk
    Vincent Cottin
    Advances in Therapy, 2023, 40 : 2038 - 2050
  • [40] Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis
    Hostettler, Katrin E.
    Zhong, Jun
    Papakonstantinou, Eleni
    Karakiulakis, George
    Tamm, Michael
    Seidel, Petra
    Sun, Qingzhu
    Mandal, Jyotshna
    Lardinois, Didier
    Lambers, Christopher
    Roth, Michael
    RESPIRATORY RESEARCH, 2014, 15
12345